Aortic stenosis, patient guide

Aortic valve stenosis occurs when calcium deposits in the valve cause leaflets hardening. It is a degenerative process that gets worse as the person ages. As the disease develops, valve opening is narrowed, obstructing blood flow and forcing the heart to pump harder. 

Aortic valve replacement is the standard treatment for severe aortic stenosis. Without treatment, a large ratio of people with severe aortic stenosis who are experiencing symptoms will die in about two years. Transcatheter implantation of the aortic valve, or TAVI, allows replacement of the aortic valve without opening the chest. This less invasive process is available for patients considered at high risk for open heart surgery.  

http://solaci.org/es/pdfs/estenosis_pacientes.pdf
SOLACI.ORG

More articles by this author

Women Present Lower Risk of Sport Related Sudden Death Compared to Men

According to this recent analysis published in Eur Heart J, women would have a far lower chances of dying suddenly for physical exertion during...

Saturated Fats: Dietary Angels or Demons?

In order to reduce cardiovascular events, dietary guidelines recommend restricting saturated fatty acids—without taking into account differences among them—to <10% of the daily caloric...

Low-Carb Diet and Coronary Artery Calcium Progression

People on low carb diets since a young age present increased risk of coronary artery calcium progression, particularly when carbs are replaced by animal...

Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...